Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
11.
Am J Law Med ; 47(2-3): 157-175, 2021 07.
Article in English | MEDLINE | ID: covidwho-1361581

ABSTRACT

The COVID-19 pandemic has revealed myriad and complex challenges for our national health care system spanning preparedness, response, access, costs, infrastructure, coordination, and medical innovation. These challenges implicate federal, state, and local agencies and actors, as well as international collaborative bodies. One constant throughout the pandemic has been the pressing need for safe and effective diagnostics, prophylactic vaccines, and drug treatments to counter the virus.1 Inarguably, significant problems with the multi-faceted system of drug and vaccine innovation and regulation manifested long before the COVID-19 pandemic.2 The pandemic, however, has laid bare the inextricable connections among federal funding, patents, product review and approval mechanisms, and the eventual medical products and resulting costs.


Subject(s)
Biological Products/economics , COVID-19/drug therapy , Drug Approval/legislation & jurisprudence , Government Agencies , Patents as Topic , Therapies, Investigational/economics , Humans , Information Dissemination , Intellectual Property , Research Support as Topic , SARS-CoV-2 , United States
14.
Lancet ; 397(10291): 2304-2308, 2021 06 12.
Article in English | MEDLINE | ID: covidwho-1265895

ABSTRACT

Strong US-China collaboration on health and medicine is a crucial element of the global effort against COVID-19. We review the history of health collaboration and exchanges between the public and private sectors in the USA and China, including the long-lasting collaboration between governmental public health agencies of the two countries. Academic and scientific exchanges should be reinvigorated and the increasing valuable role of non-profit foundations acknowledged. The shared interests of the two countries and the magnitude of the pandemic necessitate both countries to collaborate and cooperate. We provide recommendations to the two governments and the global health community to control the ongoing COVID-19 pandemic and prepare for future threats. TRANSLATION: For the Chinese translation of the abstract see Supplementary Materials section.


Subject(s)
Health , International Cooperation/history , Medicine , China , Global Health , Government Agencies , History, 20th Century , History, 21st Century , Humans , Private Sector , Public Health , Public Sector , Science , United States , Universities
15.
Int J Environ Res Public Health ; 18(10)2021 05 13.
Article in English | MEDLINE | ID: covidwho-1227030

ABSTRACT

The confined environment of a ship promotes the transmission of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) due to close contact among the population on board. The study aims to provide an overview of outbreaks of SARS-CoV-2 on board of cruise, navy or cargo ships, to identify relevant outbreak management techniques, related problems and to derive recommendations for prevention. Four databases were searched. The study selection included reports about seroprevalences or clinically/laboratory confirmed infections of SARS-CoV-2 on board ships between the first of January, 2020 and the end of July, 2020. A total of 37 studies were included of whom 33 reported outbreaks of SARS-CoV-2 on cruise ships (27 studies referred to the Diamond Princess). Two studies considered outbreaks on the Grand Princess, three studies informed about Nile River cruises and one study about the MS Westerdam (mention of multiple outbreaks possible in one study). Additionally, three studies reported outbreaks of SARS-CoV-2 on navy vessels and one study referred to a cargo ship. Problems in handling outbreaks resulted from a high number of asymptomatic infections, transportation issues, challenges in communication or limited access to health care. Responsible operators need to implement infection control measures which should be described in outbreak management plans for ships to prevent transmission risks, including, e.g., education, testing strategies, communication lines, social distancing and hygiene regulations.


Subject(s)
COVID-19 , Ships , Disease Outbreaks , Government Agencies , Humans , SARS-CoV-2
17.
Ther Innov Regul Sci ; 55(5): 1014-1018, 2021 09.
Article in English | MEDLINE | ID: covidwho-1210760

ABSTRACT

The authors aim to familiarize the reader with the Center for the State Control of Medicines, Medical Equipment and Devices (CECMED) and the agency's perspective regarding the development and implementation of regulatory sciences as an interactive tool to promote cooperation and scientific thinking. The authors share their viewpoint on the preparedness of Latin American regulatory agencies by assessing innovation (i.e. novel biopharmaceuticals, vaccines, etc.), analyzing the challenges which are impacting healthcare and patients, and posing suggestions for a collaborative regional and international approach. To conclude, the authors' share recommendations for the implementation of regional initiatives aimed at supporting regulatory science, with the goal to promote the exchange of scientific cooperation as a vital element to maximize regulatory skills and competencies.


Subject(s)
COVID-19 , Vaccines , Government Agencies , Humans , SARS-CoV-2
18.
Gac Sanit ; 35 Suppl 1: S30-S32, 2021.
Article in English | MEDLINE | ID: covidwho-1174246

ABSTRACT

OBJECTIVE: The large-scale social distancing policy conducted twice was unable to reduce the rate of development of COVID-19 widespread in Makassar, yet it increased. One of the causes was that social awareness is still lacking especially for people in the poverty line. This study attempts to describe the social behavior of people in poverty line toward COVID-19 case in Makassar. METHOD: This research is a qualitative descriptive study based on the case. The data analysis was undertaken qualitatively. RESULTS: The results revealed that the limited understanding of people in poverty line about COVID-19 and health protocols makes their behavior indifferent and disobedient to health protocols. In addition, the government's top-down approach to deal with COVID-19 pandemic was ineffective. However, bottom-up collaborative interventions need to be carried out through a group approach to gain an understanding of the COVID-19 health protocol, especially for people in poverty line and other vulnerable groups.


Subject(s)
COVID-19/prevention & control , Health Behavior , Health Knowledge, Attitudes, Practice , Intersectoral Collaboration , Pandemics , Physical Distancing , Poverty , SARS-CoV-2 , Stakeholder Participation , COVID-19/epidemiology , COVID-19/psychology , COVID-19/transmission , Community Participation , Government Agencies , Health Policy , Humans , Indonesia/epidemiology , Public Health Administration , Qualitative Research , Social Responsibility , Stakeholder Participation/psychology , Urban Population
SELECTION OF CITATIONS
SEARCH DETAIL